SUCAMPO PHARMACEUTICALS

sucampo-pharmaceuticals-logo

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA – and a late-stage pipeline of product candidates in clinical development for orphan disease areas. VTS-270 is a mixture of 2-hydroxypropyl-B-cyclodextrins with a specific compositional fingerprint that has been granted orphan designation in the U.S. and... Europe and is in a pivotal Phase 2/3 clinical trial for the treatment of Niemann-Pick Disease Type C-1. Sucampo has an option for the North American rights to CPP1- x/sulindac, which is in Phase 3 development for the treatment of familial adenomatous polyposis and has been granted orphan drug designation in the U.S. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan and Switzerland.

#SimilarOrganizations #People #Financial #Website #More

SUCAMPO PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care

Founded:
1996-01-01

Address:
Bethesda, Maryland, United States

Country:
United States

Website Url:
http://www.sucampo.com

Total Employee:
51+

Status:
Active

Contact:
3019613440

Email Addresses:
[email protected]

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS IIS 10 Microsoft CPanel Shutterstock


Similar Organizations

curtiss-healthcare-logo

Curtiss Healthcare

Curtiss Healthcare is a biopharmaceutical company.

Current Employees Featured

greg-deener_image

Greg Deener
Greg Deener Sr. VP, Global Marketing and Strategy Implementation @ Sucampo Pharmaceuticals
Sr. VP, Global Marketing and Strategy Implementation
2012-03-01

peter-greenleaf_image

Peter Greenleaf
Peter Greenleaf Chief Executive Officer and a member of our Board of Directors @ Sucampo Pharmaceuticals
Chief Executive Officer and a member of our Board of Directors

peter-lichtlen_image

Peter Lichtlen
Peter Lichtlen Senior Medical Officer and the Vice President @ Sucampo Pharmaceuticals
Senior Medical Officer and the Vice President
2011-01-01

Stock Details


Company's stock symbol is NASDAQ:SCMP

Acquisitions List

Date Company Article Price
2017-04-03 Vtesse Vtesse acquired by Sucampo Pharmaceuticals N/A
2015-10-31 R-Tech Ueno R-Tech Ueno acquired by Sucampo Pharmaceuticals N/A

Official Site Inspections

http://www.sucampo.com

  • Host name: www.sucampo.com
  • IP address: 146.214.96.210
  • Location: St Louis United States
  • Latitude: 38.6249
  • Longitude: -90.4496
  • Metro Code: 609
  • Timezone: America/Chicago
  • Postal: 63131

Loading ...

More informations about "Sucampo Pharmaceuticals" on Search Engine